AmberCRO - Company Review
AmberCRO - Company ReviewSummary
AmberCRO (Amber) is a healthcare solutions provider that offers clinical research services. The company provides protocol development, case report form, selection process, and clinical trial activities. Its services include interaction with the investigator, regulatory consultation, organize investigator meeting, study design, and site management and monitoring. Amber conducts clinical studies in therapeutic areas such as onychomycosis psoriasis, hepatitis C, prostate cancer, arterial hypertension, anti inflammatory, arterial hypertension, diabetes mellitus, pulmonary diseases, cystic fibrosis, Parkinson’s disease, and venous leg ulcers. The company caters to pharmaceutical and healthcare professionals. It provides services in the US, Russia, Ukraine, Hungaria, and other countries. Amber is headquartered in Riga, Latvia.
This comprehensive company report of AmberCRO provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.